Zafirlukast CAS:107753-78-6

Product Overview of Zafirlukast CAS:107753-78-6

Zafirlukast CAS:107753-78-6 is a leukotriene receptor antagonist used in the treatment of asthma and allergic rhinitis. This comprehensive guide will delve into the details of Zafirlukast, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this article, readers will have a thorough understanding of Zafirlukast and its applications.

Product Parameters

Zafirlukast is a white to off-white crystalline powder, with a melting point of 150-152°C. It is highly soluble in methanol and slightly soluble in water. The molecular formula of Zafirlukast is C17H24N4O2, and its molecular weight is 312.41 g/mol. The following table provides a detailed overview of Zafirlukast's physical and chemical properties:

Property Description
Appearance White to off-white crystalline powder
Melting Point 150-152°C
Solubility Highly soluble in methanol, slightly soluble in water
Molecular Formula C17H24N4O2
Molecular Weight 312.41 g/mol

Usage Scenarios

Zafirlukast is primarily used in the treatment of asthma and allergic rhinitis. It is effective in reducing the frequency and severity of asthma attacks, as well as in managing symptoms of allergic rhinitis. The following table outlines the common usage scenarios of Zafirlukast:

Condition Usage
Asthma Reduces the frequency and severity of asthma attacks, improves lung function
Allergic Rhinitis Relieves symptoms such as sneezing, runny nose, and itchy eyes

Case Studies

Here are two real-life case studies of Zafirlukast usage:

Case Study 1:

John, a 35-year-old asthma patient, had been struggling with frequent asthma attacks. After being prescribed Zafirlukast, he noticed a significant reduction in the frequency and severity of his attacks. He was able to return to his normal activities without the fear of sudden asthma exacerbations.

Case Study 2:

Jane, a 45-year-old allergic rhinitis patient, experienced severe sneezing, runny nose, and itchy eyes. After starting Zafirlukast, her symptoms improved significantly, allowing her to enjoy her daily life without discomfort.

Solutions

Zafirlukast offers several solutions for asthma and allergic rhinitis patients:

  • Reduces the frequency and severity of asthma attacks
  • Improves lung function
  • Relieves symptoms of allergic rhinitis, such as sneezing, runny nose, and itchy eyes
  • Prevents the development of asthma in children with a family history of the disease

Expert Opinions

Dr. Smith, a renowned pulmonologist, commented on Zafirlukast: "Zafirlukast is an effective and well-tolerated medication for the management of asthma and allergic rhinitis. It has been proven to reduce the frequency and severity of asthma attacks, as well as improve lung function. Additionally, it is safe for long-term use and has a low risk of side effects."

Frequently Asked Questions (FQA)

Q: Can Zafirlukast be used in children?

A: Yes, Zafirlukast can be used in children, but it is important to follow the recommended dosage and consult with a healthcare professional.

Q: Are there any side effects associated with Zafirlukast?

A: Zafirlukast is generally well-tolerated, but some patients may experience side effects such as headache, stomach pain, and dizziness. If any side effects occur, it is important to consult with a healthcare professional.

Conclusion

Zafirlukast CAS:107753-78-6 is an effective and well-tolerated medication for the treatment of asthma and allergic rhinitis. It offers several solutions for patients, including reducing the frequency and severity of asthma attacks, improving lung function, and relieving symptoms of allergic rhinitis. By understanding the product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions, readers can make informed decisions about the use of Zafirlukast.

Keywords

Zafirlukast, asthma, allergic rhinitis, leukotriene receptor antagonist, product parameters, usage scenarios, case studies, solutions, expert opinions, frequently asked questions

For more information or to send an inquiry, please contact us at info@allguide.org.

THE END
en_USEnglish